Related Experiment Video
Updated: May 10, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Evidence of preventive effect of probiotics and prebiotics for infantile eczema
1University Hospitals of Geneva and Medical School of The University of Geneva, Department of Child and Adolescent, Geneva, Switzerland. Philippe.Eigenmann@hcuge.ch
Insights
Probiotic and prebiotic supplementation may help prevent infantile eczema (atopic dermatitis). Combining these interventions from pregnancy through infancy shows greater potential than single-strain or short-term use for preventing atopic disease manifestations.
Area of Science:
- Immunology
- Microbiome research
- Pediatric allergy
Background:
- Infantile eczema, particularly atopic dermatitis, is often the initial sign of atopic predisposition in children.
- Probiotics and prebiotics represent promising interventions for preventing atopic diseases.
- Recent literature highlights the evolving strategies in this field.
Purpose of the Study:
- To review recent studies on probiotics and prebiotics for preventing infantile eczema.
- To hypothesize on the most effective intervention strategies for atopic dermatitis prevention.
- To analyze the role of microbiota modulation in early atopy.
Main Methods:
- Systematic review of recent literature on probiotic and prebiotic interventions.
- Analysis of studies administering probiotics and prebiotics during pregnancy and early infancy.
- Evaluation of combination therapies versus single-agent interventions.
Main Results:
- Combined probiotic and prebiotic administration from pregnancy to early infancy demonstrated higher protective potential against infantile eczema.
- Interventions were generally administered during late pregnancy through the first six months of life.
- The efficacy of single probiotic or prebiotic strains varied.
Conclusions:
- The impact of probiotic and prebiotic supplementation on early atopic manifestations like infantile eczema remains debated.
- Future prevention strategies should integrate microbiota-targeted interventions with other approaches, such as active antigen-specific tolerance induction.
- Optimizing intervention timing and combinations is crucial for enhanced efficacy in preventing atopic diseases.
Purpose Of Review:
Infantile eczema, and in particular atopic dermatitis are, in many children, the first manifestation of their predisposition to an atopic disease. Among existing prevention strategies, supplementation with probiotics and prebiotics belong to the most promising beneficial interventions. Highlighting the most recent literature, we review here the most recent studies on probiotics and prebiotics and hypothesize on the most efficient intervention strategies.
Recent Findings:
Various probiotics and prebiotics, either alone or in combinations, have been administered, in general, during the late phase of pregnancy and up to 6 months of age. In general, a combination of probiotics and prebiotics given from pregnancy until early infancy has a higher potential for protecting the infant from developing early manifestations of eczema than short administration of one specific microorganism.
Summary:
The effect of probiotics and prebiotic supplementations on early manifestations of atopy such as infantile eczema are conflicting. Nevertheless, prevention strategies should aim for an enhanced efficacy by addressing not only interventions on the microbiota, but by combining them to other interventions, for example, to those aiming at actively inducing antigen-specific tolerance.
More Related Videos
Related Concept Videos
Probiotics
Development of Human Microbiota
Development of the Oral Microbiota
Acne Infection
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

